These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Anticancer activity of opened arene ruthenium metalla-assemblies. Barry NP; Zava O; Furrer J; Dyson PJ; Therrien B Dalton Trans; 2010 Jun; 39(22):5272-7. PubMed ID: 20442944 [TBL] [Abstract][Full Text] [Related]
3. Thiophenolato-bridged dinuclear arene ruthenium complexes: a new family of highly cytotoxic anticancer agents. Gras M; Therrien B; Süss-Fink G; Zava O; Dyson PJ Dalton Trans; 2010 Nov; 39(42):10305-13. PubMed ID: 20890536 [TBL] [Abstract][Full Text] [Related]
4. Cellular delivery of pyrenyl-arene ruthenium complexes by a water-soluble arene ruthenium metalla-cage. Furrer MA; Schmitt F; Wiederkehr M; Juillerat-Jeanneret L; Therrien B Dalton Trans; 2012 Jun; 41(24):7201-11. PubMed ID: 22506276 [TBL] [Abstract][Full Text] [Related]
5. Anticancer activity of tetracationic arene ruthenium metalla-cycles. Barry NP; Edafe F; Therrien B Dalton Trans; 2011 Jul; 40(27):7172-80. PubMed ID: 21660364 [TBL] [Abstract][Full Text] [Related]
6. Excellent correlation between drug release and portal size in metalla-cage drug-delivery systems. Barry NP; Zava O; Dyson PJ; Therrien B Chemistry; 2011 Aug; 17(35):9669-77. PubMed ID: 21735491 [TBL] [Abstract][Full Text] [Related]
7. Anticancer activity of osmium metalla-rectangles. Barry NP; Edafe F; Dyson PJ; Therrien B Dalton Trans; 2010 Mar; 39(11):2816-20. PubMed ID: 20200707 [TBL] [Abstract][Full Text] [Related]
8. Ruthenium polypyridine complexes of tris-(2-pyridyl)-1,3,5-triazine-unusual building blocks for the synthesis of photochemical molecular devices. Schwalbe M; Karnahl M; Görls H; Chartrand D; Laverdiere F; Hanan GS; Tschierlei S; Dietzek B; Schmitt M; Popp J; Vos JG; Rau S Dalton Trans; 2009 May; (20):4012-22. PubMed ID: 19440601 [TBL] [Abstract][Full Text] [Related]
9. Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties. Ludwig G; Kaluđerović GN; Bette M; Block M; Paschke R; Steinborn D J Inorg Biochem; 2012 Aug; 113():77-82. PubMed ID: 22698819 [TBL] [Abstract][Full Text] [Related]
16. Anticancer potency studies of coordination driven self-assembled arene–Ru-based metalla-bowls. Mishra A; Jeong YJ; Jo JH; Kang SC; Lah MS; Chi KW Chembiochem; 2014 Mar; 15(5):695-700. PubMed ID: 24677392 [TBL] [Abstract][Full Text] [Related]
17. Ruthenium(II/III)-based compounds with encouraging antiproliferative activity against non-small-cell lung cancer. Nagy EM; Pettenuzzo A; Boscutti G; Marchiò L; Dalla Via L; Fregona D Chemistry; 2012 Nov; 18(45):14464-72. PubMed ID: 23012112 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, Anticancer Activity, and Genome Profiling of Thiazolo Arene Ruthenium Complexes. Grozav A; Balacescu O; Balacescu L; Cheminel T; Berindan-Neagoe I; Therrien B J Med Chem; 2015 Nov; 58(21):8475-90. PubMed ID: 26488797 [TBL] [Abstract][Full Text] [Related]
19. Ruthenium-Arene-β-Carboline Complexes as Potent Inhibitors of Cyclin-Dependent Kinase 1: Synthesis, Characterization and Anticancer Mechanism Studies. He L; Liao SY; Tan CP; Ye RR; Xu YW; Zhao M; Ji LN; Mao ZW Chemistry; 2013 Sep; 19(36):12152-60. PubMed ID: 23878093 [TBL] [Abstract][Full Text] [Related]
20. Selective cytotoxic Ru(II) arene Cp* complex salts [R-PhRuCp*](+)X(-) for X = BF4(-), PF6(-), and BPh4(-). Loughrey BT; Healy PC; Parsons PG; Williams ML Inorg Chem; 2008 Oct; 47(19):8589-91. PubMed ID: 18783214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]